Common-Size Balance Sheet: Assets
Paying user area
Try for free
Regeneron Pharmaceuticals Inc. pages available for free this week:
- Analysis of Short-term (Operating) Activity Ratios
- Analysis of Long-term (Investment) Activity Ratios
- Enterprise Value (EV)
- Price to FCFE (P/FCFE)
- Selected Financial Data since 2005
- Operating Profit Margin since 2005
- Debt to Equity since 2005
- Total Asset Turnover since 2005
- Price to Earnings (P/E) since 2005
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Regeneron Pharmaceuticals Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The asset composition of the entity demonstrates notable shifts over the five-year period. Current assets initially represent a majority of total assets, but this proportion decreases over time, while the share of noncurrent assets increases. Within current assets, a significant dynamic is observed in the allocation between cash, marketable securities, and accounts receivable.
- Liquidity Position
- The percentage of total assets held as cash and cash equivalents exhibits a consistent decline from 11.35% in 2021 to 6.59% in 2024, before a slight recovery to 7.69% in 2025. Simultaneously, marketable securities experience a more volatile pattern, increasing substantially from 11.04% in 2021 to a peak of 24.53% in 2023, then decreasing to 13.53% in 2025. This suggests a strategic shift in liquidity management, potentially involving the conversion of cash into marketable securities and then a partial reversal of this trend. Accounts receivable, net, shows a steady decrease from 23.73% to 14.16% over the period, indicating improved efficiency in collecting receivables or a change in sales terms.
- Long-Term Investments & Fixed Assets
- The proportion of total assets allocated to property, plant, and equipment, net, remains relatively stable, fluctuating between 12.18% and 13.69% throughout the period. However, intangible assets, net, experience a significant increase from 0.03% in 2021 to 3.10% in 2025, suggesting increased investment in intellectual property or other intangible resources. Deferred tax assets also demonstrate a consistent upward trend, rising from 3.45% to 10.05%, potentially reflecting changes in tax planning strategies or accumulated tax benefits. Other noncurrent assets show the most substantial relative growth, increasing from 0.85% to 4.49%, indicating expanding long-term investments beyond the traditionally categorized assets.
- Overall Asset Structure
- The balance between current and noncurrent assets shifts considerably. In 2021 and 2022, current assets comprise over half of total assets. However, by 2025, noncurrent assets represent 55.57% of the total, surpassing current assets which fall to 44.43%. This indicates a move towards a more long-term focused asset base. The combined percentage of marketable securities, both current and noncurrent, is substantial, representing approximately 30.81% of total assets in 2025, highlighting the importance of investment holdings to the entity’s overall financial position.
These changes in asset allocation suggest a dynamic financial strategy, potentially driven by evolving business needs, investment opportunities, and tax considerations. The increasing proportion of noncurrent assets indicates a long-term investment horizon and a potential shift in the entity’s operational focus.